Mylan Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 1997.

1997 Hyderabad, Telangana, India Active

Last Updated: December 18, 2025

About Mylan Pharmaceuticals Private Limited

Mylan Pharmaceuticals Private Limited, a active private limited company, was established on 03 March 1997 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U73100TG1997PTC149781. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹120.00 Cr and a paid-up capital of ₹10.00 Cr.

Formerly known as Merck Development Centre Private Limited, Mylan India Private Limited. It upholds a compliant status. Employing 3,092 professional, Its leadership includes Praveen Singh Chauhan (Whole-Time Director), Ajay Singh Rathore (Whole-Time Director). Past directors included Rajesh Ullanat, Stephen Raymond Self, Rajiv Malik. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.564/A/22, Road No.92, Jubilee Hills, Hyderabad, Telangana, 500096.

Company Details

CIN/LLPIN
U73100TG1997PTC149781
Registration Number
149781
Incorporation Date
03 March 1997
Authorized Capital
₹120.00 Cr
Paid-Up Capital
₹10.00 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 120.00 Cr as on 18-12-2025
Paid Up Capital ₹ 10.00 Cr as on 18-12-2025
Company Age 29 Year, 4 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** 95.04% (FY 2022)
Profit Growth **** 336.04% (FY 2022)
Ebitda **** 284.51% (FY 2022)
Net Worth 187.27% (FY 2022)
Total Assets **** 130.01% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Mylan Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Mylan Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Praveen Singh Chauhan	Whole-Time Director	16 Apr 2024	Current
Ajay Singh Rathore	Whole-Time Director	21 Jun 2019	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Whole-Time Director	03 Mar 2021	Past
Pramod Abcsdd	Director	01 Oct 2007	Past
Pramod Abcsdd	Additional Director	28 Mar 2008	Past
Pramod Abcsdd	Additional Director	29 Sep 2024	Past
Pramod Abcsdd	Secretary	-	Past
Pramod Abcsdd	Whole-Time Director	31 Mar 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mylan Pharmaceuticals.

Mylan Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 95.04% increase. The company also saw a substantial improvement in profitability, with a 336.04% increase in profit. The company's net worth Soared by an impressive increase of 187.27%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

95.04%

*******

Revenue from Operations

*******

95.01%

*******

Total Assets

*******

130.01%

*******

Profit or Loss

*******

336.04%

*******

Net Worth

*******

187.27%

*******

EBITDA

*******

284.51%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mylan Pharmaceuticals?

In 2023, Mylan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Mylan Pharmaceuticals?

Mylan Pharmaceuticals has a workforce of 3092 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Mylan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mylan Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mylan Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

The activity Mylan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
30 Sep 2025
Balance Sheet

Progress on Mylan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
31 Mar 2025
Director Appointment

The activity Praveen Singh Chauhan was appointed as a Whole-time director was appointed as a Whole-time director on 16 Apr 2024 & has been associated with this company since 2 years 2 months . was completed.
16 Apr 2024
Director Appointment

The activity Ajay Singh Rathore was appointed as a Whole-time director was appointed as a Whole-time director on 21 Jun 2019 & has been associated with this company since 7 years 15 days . was completed.
21 Jun 2019
Director Appointment

The activity Rekha Lakhotiya was appointed as a Company Secretary was appointed as a Company Secretary on 03 Dec 2015 & has been associated with this company since 10 years 7 months . was completed.
03 Dec 2015
Company Incorporation

The activity Mylan Pharmaceuticals Private Limited was registered on 03 Mar 1997 with Roc Hyderabad & aged 29 years 4 months as per MCA records. was completed.
03 Mar 1997

Explore recent activity and updates - View Recent Activity